Latest Breaking News On - Paul matteis - Page 1 : comparemela.com

FDA analysis raises no major concerns about Eli Lilly Alzheimer's drug

An FDA analysis of trial data for Eli Lilly s experimental Alzheimer s drug donanemab released on Thursday revealed no red flags, but raised questions about safety of the treatment for patients with early-stage disease.

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75.

Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript

Biogen Inc. misses on earnings expectations. Reported EPS is $3.3 EPS, expectations were $3.45.

Biogen (BIIB) Q1 2024 Earnings Call Transcript

BIIB earnings call for the period ending March 31, 2024.